SCHEMBL3172362

SCHEMBL3172362

CC(=O)NCCNc1nc(-c2ccc(Cl)cc2)nc(NCCNC(=O)c2cccc(C(F)(F)F)c2)c1C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
POLB P06746 1/20 0.50
TP53BP1 Q12888 1/20 0.46
MAPT P10636 4/20 0.45
DDR1 Q08345 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
TP53 P04637 1/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44
ADORA3 P0DMS8 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ABL1 P00519 1/20 0.43
BCR P11274 1/20 0.43
PPARG P37231 2/20 0.43
SLC22A12 Q96S37 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172317 0.92 ADORA2A (0.53) ALDH1A1POLBTP53BP1MAPTRXFP1
SCHEMBL3172187 0.88 ALDH1A1 (0.54) ALDH1A1MAPTADORA2AADORA1TP53
SCHEMBL3170464 0.86 L3MBTL1 (0.48) ALDH1A1TP53BP1MAPTADORA2AADORA1
SCHEMBL3156001 0.85 ADORA2A (0.56) ALDH1A1POLBMAPTADORA2AADORA1
SCHEMBL3167813 0.83 ADORA2A (0.56) ALDH1A1MAPTADORA2AADORA1TP53
SCHEMBL3163059 0.83 ALDH1A1 (0.46) ALDH1A1MAPTADORA2AADORA1TP53
SCHEMBL3156347 0.82 TP53 (0.52) ALDH1A1POLBMAPTADORA2AADORA1
SCHEMBL3175707 0.82 ALDH1A1 (0.53) ALDH1A1POLBMAPTADORA2AADORA1
SCHEMBL3258726 0.81 ADORA2A (0.57) ALDH1A1POLBMAPTRXFP1ADORA2A
SCHEMBL3163026 0.81 MEN1 (0.50) ALDH1A1POLBMAPTADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed